Terri Kemmerer
Family · Gainesville, GANPI 1013199587
Payments from drug & device makers
Across 89 payments — averaging $62.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$810
- Medtronic$616
- Novo Nordisk$547
- AstraZeneca$545
- Sanofi-aventis U.S. LLC$454
- Boehringer Ingelheim$291
- plus $2K from 18 others
What the payments were for
- Travel & lodging$230%
- Food & beverage$5,53899%
- Education$431%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 15 | $810 |
| Medtronic | 8 | $616 |
| Novo Nordisk | 8 | $547 |
| AstraZeneca | 5 | $545 |
| Sanofi-aventis U.S. LLC | 5 | $454 |
| Boehringer Ingelheim | 5 | $291 |
| Lilly USA, LLC | 9 | $264 |
| Insulet Corporation | 2 | $237 |
| Amgen | 2 | $222 |
| Intuity Medical Inc | 2 | $221 |
| Xeris Pharmaceuticals, Inc. | 11 | $200 |
| Mannkind Corporation | 3 | $182 |
| GSK | 2 | $165 |
| AbbVie | 2 | $132 |
| Bayer | 1 | $122 |
| Idorsia Pharmaceuticals US Inc | 1 | $113 |
| Sanofi Pasteur Inc. | 1 | $95 |
| Nestle Healthcare Nutrition Inc. | 1 | $91 |
| Alkermes, Inc. | 1 | $80 |
| E.r. Squibb & Sons, L.L.C. | 1 | $75 |
| Amarin Pharma, Inc. | 1 | $67 |
| Dexcom, Inc. | 1 | $29 |
| Tandem Diabetes Care, Inc. | 1 | $29 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$388
- TZIELD$250
- Omnipod$237
- MINIMED 780G$233
- FARXIGA$232
- FREESTYLE LIBRE 3$224
- Ozempic$211
- EVENITY$133
- Pogo Automatic Blood Glucose Monitoring System$128
- FASENRA$125
- Kerendia$122
- AFREZZA$119
- QUVIVIQ$113
- RYBELSUS$109
- BREZTRI$105
- MOUNJARO$102
- ClosureFast$101
How this compares
$5,603 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 231 | $261,485 |
| OzempicSemaglutide | 151 | $194,336 |
| JardianceEmpagliflozin | 78 | $96,606 |
| Tresiba Flextouch U-200Insulin Degludec | 36 | $80,012 |
| Tresiba Flextouch U-100Insulin Degludec | 77 | $70,876 |
| TrulicityDulaglutide | 44 | $63,313 |
| FarxigaDapagliflozin Propanediol | 48 | $53,201 |
| RybelsusSemaglutide | 24 | $50,211 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 23 | $36,167 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 25 | $24,481 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $18,061 |
| JanuviaSitagliptin Phosphate | 12 | $18,006 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $16,469 |
| NovologInsulin Aspart | 40 | $13,845 |
| Novolog FlexpenInsulin Aspart | 53 | $12,343 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog | $264 | $331,442296 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $547 | $258,392215 claims |
| Boehringer IngelheimJardiance, Synjardy | $291 | $107,47090 claims |
| AstraZenecaFarxiga | $545 | $53,20148 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $454 | $24,48125 claims |
| AbbVieSynthroid | $132 | $5,04557 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.
Other family in Gainesville
- Kristina JamesGainesville$16K
- Leigh DayGainesville$16K
- Jeanette PirkleGainesville$15K
- Jennifer ButlerGainesville$14K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.